Related Experiment Video
Updated: Sep 3, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
Host Respiratory Transcriptome Signature Associated with Poor Outcome in Children with Influenza-Staphylococcus
Carl Britto1,2,3, Irina Mohorianu2,4, Tracy Yeung5
1Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Abstract:
Respiratory coinfection of influenza with Staphylococcus aureus often causes severe disease; methicillin-resistant S. aureus (MRSA) coinfection is frequently fatal. Understanding disease pathogenesis may inform therapies. We aimed to identify host and pathogen transcriptomic (messenger RNA) signatures from the respiratory compartment of pediatric patients critically ill with influenza-S. aureus coinfection (ISAC), signatures that predict worse outcomes. Messenger RNA extracted from endotracheal aspirate samples was evaluated for S. aureus and host transcriptomic biosignatures. Influenza-MRSA outcomes were worse, but of 190 S. aureus virulence-associated genes, 6 were differentially expressed between MRSA-coinfected versus methicillin-susceptible S. aureus-coinfected patients, and none discriminated outcome. Host gene expression in patients with ISAC was compared with that in patients with influenza infection alone. Patients with poor clinical outcomes (death or prolonged multiorgan dysfunction) had relatively reduced expression of interferons and down-regulation of interferon γ-induced immune cell chemoattractants CXCL10 and CXCL11. In ISAC, airway host but not pathogen gene expression profiles predicted worse clinical outcomes.
Insights
Severe influenza-Staphylococcus aureus coinfection (ISAC) in children is linked to poor outcomes. Reduced host immune gene expression, specifically interferons and related chemoattractants, predicts worse clinical results in ISAC patients.
Area of Science:
- Microbiology
- Immunology
- Genomics
Background:
- Influenza and Staphylococcus aureus coinfection, particularly with methicillin-resistant S. aureus (MRSA), leads to severe, often fatal, disease in pediatric patients.
- Understanding the molecular mechanisms of this coinfection is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To identify host and pathogen transcriptomic signatures in the respiratory tract of critically ill children with influenza-S. aureus coinfection (ISAC).
- To determine if these signatures can predict worse clinical outcomes.
Main Methods:
- Messenger RNA (mRNA) was extracted from endotracheal aspirate samples of pediatric patients.
- Evaluated S. aureus virulence genes and host gene expression profiles.
- Compared transcriptomic data between patients with different coinfection statuses and clinical outcomes.
Main Results:
- While influenza-MRSA coinfection showed worse outcomes, only 6 of 190 S. aureus virulence genes were differentially expressed between MRSA and methicillin-susceptible S. aureus coinfections, with no predictive value for outcome.
- Patients with poor outcomes (death or prolonged dysfunction) exhibited reduced expression of interferons and down-regulation of interferon γ-induced immune cell chemoattractants (CXCL10 and CXCL11).
- Host airway gene expression profiles, not pathogen profiles, predicted worse clinical outcomes in ISAC.
Conclusions:
- Host transcriptomic signatures in the airway are key predictors of clinical outcomes in pediatric influenza-S. aureus coinfection.
- Reduced expression of specific host immune genes, including interferons and related chemokines, is associated with severe disease and poor prognosis in ISAC.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III
Pneumonia II: Pathophysiology
Acute Respiratory Failure-IV